Table 2.
Acute Lymphoblastic Leukemia | Acute Myeloid Leukemia | |||||
---|---|---|---|---|---|---|
Characteristic | HR (95% CI) | Pairwise P | Overall P | HR (95% CI) | Pairwise P | Overall P |
Sphere Distance to Center | ||||||
≤10 Miles v. >50 Miles | 1.04 (0.96–1.13) | 0.29 | <.0001 | 1.05 (0.98–1.13) | 0.20 | 0.0066 |
10–20 Miles v. >50 Miles | 0.76 (0.69–0.84) | <.0001 | 0.94 (0.87–1.03) | 0.18 | ||
20–50 Miles v. >50 Miles | 0.76 (0.70–0.84) | <.0001 | 0.93 (0.86–1.01) | 0.10 | ||
Charlson-Deyo Score | ||||||
0 v. 3 | 0.30 (0.20–0.43) | <.0001 | <.0001 | 0.41 (0.31–0.56) | <.0001 | <.0001 |
1 v. 3 | 0.53 (0.35–0.79) | 0.0018 | 0.61 (0.44–0.84) | 0.0023 | ||
2 v. 3 | 0.91 (0.56–1.50) | 0.71 | 0.92 (0.62–1.35) | 0.66 | ||
Gender | ||||||
Male v. Female | 1.16 (1.09–1.24) | <.0001 | <.0001 | 1.02 (0.97–1.08) | 0.4276 | 0.4276 |
Race | ||||||
African American v. Caucasian | 1.57 (1.41–1.74) | <.0001 | <.0001 | 1.33 (1.23–1.44) | <.0001 | <.0001 |
Asian v. Caucasian | 0.95 (0.80–1.12) | 0.54 | 0.97 (0.85–1.10) | 0.62 | ||
Hispanic/Latinos v. Caucasian | 1.48 (1.38–1.59) | <.0001 | 0.94 (0.86–1.01) | 0.11 | ||
Native American v. Caucasian | 1.72 (1.25–2.37) | 0.0009 | 1.03 (0.76–1.40) | 0.84 | ||
Others v. Caucasian | 0.91 (0.68–1.23) | 0.54 | 0.74 (0.55–1.00) | 0.0477 | ||
Insurance | ||||||
Government v. Private | 1.27 (1.19–1.36) | <.0001 | <.0001 | 1.20 (1.13–1.27) | <.0001 | <.0001 |
Not Insured v. Private | 2.59 (2.32–2.89) | <.0001 | 1.39 (1.25–1.54) | <.0001 | ||
Community Median Income | ||||||
< $38,000 v. ≥ $63,000 | 1.72 (1.57–1.88) | <.0001 | <.0001 | 1.32 (1.21–1.42) | <.0001 | <.0001 |
$38,000– $63,000 v. ≥ $63,000 | 1.35 (1.26–1.46) | <.0001 | 1.17 (1.10–1.26) | <.0001 | ||
Age | ||||||
≥18 v. <18 | 5.56 (5.22–5.92) | <.0001 | <.0001 | 1.56 (1.46–1.67) | <.0001 | <.0001 |
Rural | ||||||
Yes v. No | 0.89 (0.67–1.19) | 0.43 | 0.4325 | 0.97 (0.77–1.21) | 0.76 | 0.76 |